1887

Abstract

Summary

The role of the herpes simplex virus (HSV)-encoded ribonucleotide reductase (RR) in the pathogenicity of the virus has been examined by use of mutants with lesions in either the large or small subunit of the enzyme. The virulence of the mutants in mice was reduced by about 10-fold when compared with that of the parental virus (HSV type 1 strain 17), while the virulence of a revertant of one of the mutants was restored to within about 100-fold of that of the parent virus. These experiments demonstrate that activity of the HSV RR is essential for virus pathogenicity in mice and suggests that the enzyme is a valid target for specific antiviral compounds.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-10-2607
1988-10-01
2021-10-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/10/JV0690102607.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-10-2607&mimeType=html&fmt=ahah

References

  1. BACCHETTI S., EVELEGH M. J., MUIRHEAD B. 1986; Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase. Journal of Virology 57:1177–1181
    [Google Scholar]
  2. BALFOUR H. H. JR, BEAN B., MITCHELL C. C, SACHS G. W., BOEN J. R., EDELMAN C. K. 1982; Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at an institution. American Journal of Medicine 73:241–248
    [Google Scholar]
  3. BROWN S. M., RITCHIE D. A., SUBAK-SHARPE J. H. 1973; Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. Journal of General Virology 18:329–346
    [Google Scholar]
  4. COHEN E. A., CHARRON J., PERRET J., LANGELIER Y. 1985; Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2. Journal of General Virology 66:733–745
    [Google Scholar]
  5. COHEN E. A., GAUDREAU P., BRAZEAU P., LANGELIER Y. 1986; Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature, London 321:441–443
    [Google Scholar]
  6. COHEN E. A., PARADIS H., GAUDREAU P., BRAZEAU P., LANGELIER Y. 1987; Identification of viral polypeptides involved in Pseudorabies virus ribonucleotide reductase activity. Journal of Virology 61:2046–2049
    [Google Scholar]
  7. COHEN G. H. 1972; Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus. Journal of Virology 9:408–418
    [Google Scholar]
  8. DUTIA B. M. 1983; Ribonucleotide reductase induced by herpes simplex virus has a virus-specified constituent. Journal of General Virology 64:513–521
    [Google Scholar]
  9. DUTIA B. M., FRAME M. C, SUBAK-SHARPE J. H., CLARK W. N., MARSDEN H. S. 1986; Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature, London 321:439–441
    [Google Scholar]
  10. ELION G. B., FURMAN P. A., FYFE J. A. 1977; Selectivity of action of an antiherpetic agent, 9-1(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences, U.S.A 74:5716–5720
    [Google Scholar]
  11. FIELD H. J., COHEN D. M. 1986; Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. Journal of Virology 60:286–289
    [Google Scholar]
  12. FIELD H. J., WILDY P. 1978; The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. Journal of Hygiene 81:261–277
    [Google Scholar]
  13. FRAME M. C, MARSDEN H. S., DUTIA B. M. 1985; The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K). Journal of General Virology 66:1581–1587
    [Google Scholar]
  14. GOLDSTEIN D. J., WELLER S. K. 1988; Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. Journal of Virology 62:196–205
    [Google Scholar]
  15. INGEMARSON R., LANKINEN H. 1987; The herpes simplex virus type 1 ribonucleotide reductase is a tight complex of the type composed of 40K and 140K proteins, of which the latter shows multiple forms due to proteolysis. Journal of Virology 156:417–422
    [Google Scholar]
  16. LARDER B. A., LISLE J. J., DARBY G. 1986; Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1. Journal of General Virology 67:2501–2506
    [Google Scholar]
  17. LITCHFIELD J. T., WILCOXON F. 1949; A simple method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics 96:99–118
    [Google Scholar]
  18. MCCLEMENTS W., YAMANAKA G., GARSKY V., PERRY H., BACCHETTI S., COLONNO R., STEIN R. B. 1988; Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology 162:270–273
    [Google Scholar]
  19. MARSDEN H. S. 1987 Herpes simplex virus glycoproteins and pathogenesis. Molecular Basis of Virus Disease259–288 Edited by Russell W. C., Almond J. W. Cambridge: Cambridge University Press;
    [Google Scholar]
  20. NUTTER L. M., GRILL S. P., CHENG Y.-C. 1985; Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?. Biochemical Pharmacology 34:777–780
    [Google Scholar]
  21. PLOTKIN S. A., STARR S. E., BRYAN C. K. 1982; In vitro and in vivo responses of cytomegalovirus to acyclovir. American Journal of Medicine 73:257–261
    [Google Scholar]
  22. PRESTON V. G., PALFREYMAN J. W., DUTIA B. M. 1984; Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase. Journal of General Virology 65:1457–1466
    [Google Scholar]
  23. PRESTON V. G., DARLING A. J., MCDOUGALL I. 1988; The herpes simplex virus type 1 temperature-sensitive mutant ts\222 has a single base pair deletion in the small subunit of ribonucleotide reductase. Virology in press
    [Google Scholar]
  24. SALAHUDDIN S. Z., ABLASHI D. V., MARKHAM P. D., JOSEPHS S. F., STURZENEGGER S., KAPLAN M., HALLIGAN G., BIBERFELD P., WONG-STAAL F., KRAMARSKY B., GALLO R. C. 1986; Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601
    [Google Scholar]
  25. TENSER R. B., MILLER R. L., RAPP F. 1979; Trigeminal ganglion infection of thymidine kinase-negative mutants of herpes simplex virus. Science 205:915–918
    [Google Scholar]
  26. THELANDER L., REICHARD P. 1979; Reduction of ribonucleotides. Annual Review of Biochemistry 48:133–158
    [Google Scholar]
  27. THOMPSON R. L., STEVENS J. G. 1983; Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology 131:171–179
    [Google Scholar]
  28. WADE J. C, HINTZ M., MCGUFFIN R. W., SPRINGMEYER S. C., CONNOR J. D., MYERS J. D. 1982; Treatment of cytomegalovirus pneumonia with high-dose acyclovir. American Journal of Medicine 73:249–256
    [Google Scholar]
  29. WILDY P. 1985; Herpesviruses: a background. British Medical Bulletin 41:339–344
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-10-2607
Loading
/content/journal/jgv/10.1099/0022-1317-69-10-2607
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error